期刊文献+

血清25-羟基维生素D检测在慢性心力衰竭患者心功能分级评价中的作用 被引量:7

The role of detection serum 25-hydroxy vitamin D in the cardiac function grading and evaluation of chronic heart failure patients
下载PDF
导出
摘要 目的探讨血清25-羟基维生素D浓度在诊断慢性心力衰竭(CHF)及心功能分级评价中的作用。方法选107例CHF患者,采用彩色多普勒超声心动图仪测定左室射血分数(LVEF),依据纽约心脏病协会(NYHA)分级方案对CHF患者进行心功能分级。取血测定血清25-羟基维生素D及血浆脑钠肽(BNP)水平,观察血清25-羟基维生素D与BNP及LVEF的相关性。结果 107例慢性心力衰竭患者血清25-羟基维生素D水平与血浆BNP浓度呈负相关(r=-0.424,P<0.01),与LVEF呈正相关(r=0.421,P<0.01)。结论 CHF患者血清25-羟基维生素D水平随着心力衰竭严重程度的增加而降低,血清25-羟基维生素D水平可以准确评价心功能,可作为临床诊断、疗效观察以及预后判断CHF的客观指标。 Objective To explore the role of detection serum 25 - hydroxy vitamin D in the cardiac function grading and evaluation of chronic heart failure patients (CHF). Methods 107 CI-IF patients were included into this study. All these patients diagnosis and grading was ac- cording to New York Heart Association (NYHA) grading scheme. The LVEF was determined by colorful ultrasonic cardiogram. The serum 25 - hydroxyitamin D and plasma brain natriuretic peptide (BNP) levels were detected. The correlation was observed between serum 25 -hydroxyitamin D, plasma brain natriuretic peptide (BNP) and LVEF. Results The serum 25 - hydroxyitamin D level of 107 CHF patients decreased with the CHF grade increasing. The relationship of serum 25 - hydruxyitamin D level and plasma BNP was negative correlationship ( r = - O. 424, P 〈 O. 01 ). The relationship of serum 25 - hydroxyitamin D level and LVEF was positive correlationship ( r = - 0. 424, P 〈 0.01 ). Conclusion The se- rum 25 - hydroxyitamin D level can evaluate correctly the heart function, which can be considered as clinical diagnosis and prognostic judgment of CHF objective indicator.
作者 刘冰
出处 《临床和实验医学杂志》 2013年第16期1285-1286,共2页 Journal of Clinical and Experimental Medicine
关键词 慢性心力衰竭 心功能 血清25-羟基维生素D 脑钠肽 左室射血分数 Chronic heart failure Cardiac function Serum 25 -hydroxyitamin D Brain natriuretic peptide LVEF
  • 相关文献

参考文献11

  • 1Nishikimi T, Kuwahara K, Nakao K. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides [J]. J Cardiol, 2011,57(2) :131 - 140.
  • 2Vanderheyden M, Vrints C, Verstreken S, et al. B -type natriuretic peptide as a marker of heart failure : new insights from biochemistry and clinical implications [ J ]. Biomark Med, 2010,4 ( 2 ) : 315 - 320.
  • 3Apple FS, Wu AH, Jaffe AS, et al. National Academy of Clinical Bio- chemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines : analytical issues for bi- omarkers of heart failure [J]. Clin Biochem, 2008,41 ( 4 - 5 ) : 222 - 226.
  • 4Lee W, Kang PM. Vitamin D deficiency and cardiovascular disease: Is there a role for vitamin D therapy in heart failure[J]? Curr Opin Investig Drugs, 2010 ,11(3) :309 -314.
  • 5胡丙清,陈森.心衰患者脑钠肽与左室射血分数等参数的研究[J].中华全科医学,2011,9(11):1686-1686. 被引量:20
  • 6罗嘉宏,梁茜.血浆脑钠肽水平在心力衰竭诊断中的应用价值[J].临床和实验医学杂志,2010,9(13):966-967. 被引量:20
  • 7Kim DH, Sabour S, Sagar UN, et al. Prevalence of hypovitaminosis D in cardiovascular diseases ( from the National Health and Nutrition Ex- amination Survey 2001 to 2004) [ J ]. Am J Cardiol, 2008,102 ( 11 ) : 1540 - 1544.
  • 8Brannon PM, Yetley EA, Bailey RL, Picciano MF. Summary of roundt- able discussion on vitamin D research needs[ J]. Am J Clin Nutr,2008, 88(2) :587S- 592S.
  • 9Gupta GK, Agrawal T, DelCore MG, et al. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hy- percholesterolemic swine. [ J]. Exp Mol Pathol, 2012,93 ( 1 ) :82 - 90.
  • 10Zittermann A, Pilz S, Borgermann J, Gummert JF. Vitamin D : cardiovascular disease and mortality[ J ]. Future Cardiol, 2011,7 ( 6 ) :725 - 727.

二级参考文献20

  • 1杨兴生,孙静平.心脏利尿钠肽的应用进展[J].中国医刊,2005,40(2):10-12. 被引量:2
  • 2邵乐文,韩阳,王战坤,孙坚.床边即时脑钠肽检测对心力衰竭患者的诊断价值[J].中华内科杂志,2005,44(2):99-101. 被引量:40
  • 3刘辉,孙振学,邸茹杰,于显钊.心力衰竭患者心脏利钠肽动态变化的临床研究[J].武警医学,2006,17(11):811-812. 被引量:3
  • 4冯莉,倪新海,杨跃进.心脏利钠肽类激素在心力衰竭诊断中的应用进展[J].心血管病学进展,2007,28(3):381-385. 被引量:8
  • 5Dries DL, Stevenscen LW. Brain natriuretic peptide as bridge to the therapyfor heart failure[ J ]. Lancet,2000,355 (9210) : 1112-1113.
  • 6Mclean AS, Tang B, Nalos M, et al. Increased B-type natriuretic peptide(BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients [ J ]. Anaesth Intensive Care, 2003,31 ( 1 ) : 21- 27.
  • 7Suzuki T, Yamazaki T, Yazaki Y. The role of the natriuretic peptide in the cardiovascular system [ J ]. Cardiovasc Res, 2001,51 ( 3 ) :489-494.
  • 8Kone BC. Moleculro biology of natriuretic peptides and nitric oxide synthases[ J ]. Cardiovasc Res,2001,51 ( 3 ) :429.
  • 9Jortani SA,Prabha SD,Valdes R Jr. Strategies for developing biomarkers of heart failure [ J ]. Clin Chem, 2004,50 ( 2 ) : 265-278.
  • 10Goenning BA, Nillsson JC, Sandergaard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations [ J ]. Eur J Heart Fail, 2001,3 (6) :6991-7008.

共引文献37

同被引文献54

  • 1Yuedi Ding, Ying Peng, Lili Deng, et al. The effects of fusion structure on the expression and bioactivity of human brain natriuretic peptide (bnp) albumin fusion proteins[ J]. Curr Pharm Biotechnol, 2014,15(9) :856-863.
  • 2WANG S,QU X,QU Y, et al. The effect of b-type brain natriuretic peptide on patients with acute decompensated heart failure coexisting with lung cancer: a randomized controlled clinical trial [ J ]. PHARMAZIE, 2014,69 ( 3 ) : 212-216.
  • 3Turakhia MP, Schiller NB, Whooley MA. Prognstie signifi- cance of increase left ventrieular mass index to mortality and sudden death in patients with stable coronary heart disease (from the heart and soul study) [-J]. Am J Cardiol, 2008, 102(9) ~ 1131-1135.
  • 4潘年波.心脏彩超与心电图在心室肥厚诊断中的应用价值及对比研究[J].中外健康文摘,2014,(14):185-186.
  • 5Chen RH, Jiang XZ, Zhao XH, et al. Risk factors of mild cognitive im- pairment in middle aged patients with type 2 diabetes : a cross - section study[ J]. Ann Endocrinol (Paris) ,2012,73 (3) :208 - 212.
  • 6Strawbridge RJ, Deleskog A; MeLeod O, et al. A'serum 25 - hydroxyvitamin D concentration - associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclero- sis ( measured by carotid intima - media thickness) [ J ]. Diabetologia, 2014 ,57(6) :1159 - 1172.
  • 7Ma H, Lin H, Hu Y, et al. Serum 25 - hydroxyvitamin D levels are as- sociated with carotid atherosclerosis in normotensive and euglycemic Chi- nese postmenopausal women: the Shanghai Changfeng study[ J]. BMC Cardiovasc Disord ,2014, 14 : 197.
  • 8Introduction: The American Diabetes Association's ( ADA ) evidence - based practice guidelines, standards, and related recommendations and documents for diabetes care[J]. Diabetes Care,2012,35 Suppl 1 :S1 -2.
  • 9Chen RH, Jiang XZ, Jiang Q, et al. Correlations between serum levels of 25 - hydroxyvitamin D and carotid atherosclerosis in patients with type 2 diabetes in Shanghai[ J]. Ann Endocrinol,2014,75 (4) :206 - 212.
  • 10Chen RH, Zhao XH, Gu Z, et al. Serum levels of 25 - hydmxyvitamin D are associated with cognitive impairment in type 2 diabetic adults[ J]. Endocrine .2014.45 (2 ) :319 - 324.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部